openPR Logo
Press release

Embolotherapy Market is Anticipated to Expand and Reach US$ 7.13 Billion by the end of 2028 with 9.3% CAGR

09-07-2022 02:23 PM CET | Health & Medicine

Press release from: emergen research

Embolotherapy Market | size | share

Embolotherapy Market | size | share

The global embolotherapy market size reached USD 3.50 Billion in 2020 and is expected to register a revenue CAGR of 9.3%, during the forecast period, according to latest analysis by Emergen Research. One of the main factors propelling the expansion of the worldwide embolotherapy market's revenue is the rising prevalence of chronic diseases including cancer, peripheral artery disease, and neurological disorders, among others. The continuous shift away from invasive open surgical procedures and toward minimally invasive techniques is anticipated to fuel revenue growth for the global embolotherapy market.

Increasing demand for image-guided minimally invasive interventions have not only broadened the scope of vascular pathologies that can be treated, but has also resulted in reduction of post-operative morbidity compared to open surgical techniques. Embolization is an advanced form of treatment option whereby tiny equipment is used to navigate the body's vasculature without the need for using wound incision or open surgery. This enables reduced complication rates, increases success rate, and improves quality of life of patients.

Claim Your FREE Sample Copy with Table of content@ https://www.emergenresearch.com/request-sample/763

The report provides a sophisticated analysis of the insightful data of the Embolotherapy Market  industry that has been formulated based on thorough primary and secondary research. The details have further been validated and verified by the industry experts. The precise data offered by the report offers fruitful information about sales strategies to improve market performance.

Effect of COVID-19 on the market for embolotherapy globally

Sales of embolotherapy are declining, and it is expected that this trend will continue through the end of 2020. Unfavorable changes in legislation and norms are limiting the growth of this industry. The CDC, WHO, MHRA, TGA, and EMA, among other important international regulatory organisations, have found that adults without cancer are more likely than healthy adults to get COVID-19 infection. Therefore, screening, diagnostic tests, and surgical operations are significantly constrained or delayed at hospitals and cancer treatment centres. This will probably have a negative impact on the embolotherapy market.

Some Key Highlights From the Report :

The microspheres segment accounted for the largest share of the embolotherapy market, by product, in 2020

Detachable balloons, embolic plug systems, support devices, and embolization coils (detachable coils and pushable coils) make up the majority of the five product categories that make up the market for embolotherapy (microcatheters and guidewires). The embolic agents microspheres segment held the largest market share in 2020. One of the main factors promoting the growth of this market segment is the frequent usage of microspheres in the treatment of hepatocellular carcinoma, combined with favourable reimbursement criteria in developed nations. The introduction of new products and regulatory approvals are also helping this market category to grow.

Transcatheter Arterial Embolization (TAE) procedure attributes to rising preference for minimally invasive surgeries

 The transcatheter arterial embolization (TAE), transcatheter arterial chemoembolization (TACE), and transcatheter arterial radioembolization (TARE)/selective internal radiation therapy market segments are based on procedure (SIRT). The substantial proportion of the transcatheter arterial embolization segment is mostly due to the rising demand for less invasive procedures, the prevalence of chronic diseases, and the quick growth in the geriatric population.

The Hospitals and Clinics end user segment garnered the highest revenue in the embolotherapy market in 2020

 The embolotherapy market is divided into hospitals and clinics, ambulatory surgery centres (ASCs), and other end users depending on who would be using it. The primary end users of embolotherapy equipment are hospitals and clinics. This market segment includes products used in critical care units, minor clinics, and large hospitals for embolotherapy. The main factors that are anticipated to drive the demand for embolization devices in hospitals and clinics are the growing adoption of minimally invasive surgical procedures (including vascular, urological, and neurological procedures), increasing purchasing power of major healthcare providers across developed countries (due to the consolidation of healthcare providers), and the greater availability of reimbursements for target procedures in the US and major European countries.

Click to access the Report Study, Read key highlights of the Report and Look at Projected Trends:   https://www.emergenresearch.com/industry-report/embolotherapy-market

The prominent players participating in this industry include:

Abbott Laboratories, Boston Scientific Corporation, Medtronic PLC, Terumo Medical Corporation, Penumbra Inc., Johnson & Johnson, Merit Medical Systems Inc., Cook Medical Inc., Kaneka Corporation, and Stryker Corporation.

Emergen Research has segmented the global embolotherapy market on the basis of product, procedure, application, end-use, and region:

Product Outlook (Revenue, USD Billion; 2018-2028)

Embolic Agents

Liquid Embolic Agents

Microspheres

Embolization Coils

Detachable Coils

Pushable Coils

Detachable Balloons

Embolic Plug Systems

Support Devices

Microcatheters

Guidewires

Procedure Outlook (Revenue, USD Billion; 2018-2028)

Transcatheter Arterial Embolization

Transcatheter Arterial Radioembolization

Transcatheter Chemoembolization

Application Outlook (Revenue, USD Billion; 2018-2028)

Cancer

Peripheral Vascular Disease

Neurological Disease

Urological & Nephrological Disorders

Others

End-use Outlook (Revenue, USD Billion; 2018-2028)

Hospitals & Clinics

Ambulatory Surgical Centers

Others

 Request customization of this report @ https://www.emergenresearch.com/request-for-customization/763

Global Embolotherapy Market has been classified into the subsequent geographical segments:

North America (U.S., Canada, Mexico)

Europe (U.K., Italy, Germany, France, Rest of EU)

Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)

Latin America (Chile, Brazil, Argentina, Rest of Latin America)

Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Objectives of the Global Embolotherapy Market Study:

An extensive study of the product portfolios of the major market players and their regional presence

A closer look at the strategic initiatives undertaken by the leading companies across this industry, including mergers & acquisitions, collaborations, partnerships, and joint ventures

An in-depth study of the evolving market sectors and the growth & penetration status of the global Embolotherapy Market

COVID-19 Impact Analysis to highlight the major opportunities and challenges

Strategic recommendations to help readers formulate lucrative business strategies

Identification of the emerging players and their tactical approaches to expand market presence

Request A Sample Copy @ https://www.emergenresearch.com/request-sample/763

Contact us

Eric Lee

Corporate Sales Specialist

14671 110 Avenue, Surrey, British Columbia, V3R2A9

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Emergen Research Media Citations: https://www.emergenresearch.com/media-citations

Visit for More Insights: https://www.emergenresearch.com/insights

Custom Intelligence services https://www.emergenresearch.com/custom-intelligence

Growth Consulting Services https://www.emergenresearch.com/growth-consultant

About Emergen Research

Emergen research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client's make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Embolotherapy Market is Anticipated to Expand and Reach US$ 7.13 Billion by the end of 2028 with 9.3% CAGR here

News-ID: 2727192 • Views:

More Releases from emergen research

Global Internet of Things (IoT) in Healthcare Market to Reach USD 299.05 Billion in 2023, Set for Strong Growth at 16.5% CAGR
Global Internet of Things (IoT) in Healthcare Market to Reach USD 299.05 Billion …
The global Internet of Things (IoT) in Healthcare Market was valued at USD 299.05 billion in 2023 and is expected to grow at a CAGR of 16.5% during the forecast period. This growth is fueled by the rising use of connected healthcare devices, increasing demand for early disease detection through remote monitoring, and growing adoption of artificial intelligence (AI) tools within IoT-based healthcare systems. The market is also benefiting from the
Global Stem Cell Therapy Market to Reach USD 49.2 Billion by 2034, Growing at 13.6% CAGR
Global Stem Cell Therapy Market to Reach USD 49.2 Billion by 2034, Growing at 13 …
The global Stem Cell Therapy Market, valued at USD 13.7 billion in 2024, is projected to reach USD 49.2 billion by 2034, expanding at a compound annual growth rate (CAGR) of 13.6%. Growth is being fueled by the rising burden of chronic diseases, rapid progress in cell-based studies, and increasing investments in regenerative medicine and personalized healthcare solutions. Stem cell therapies offer the ability to repair, replace, or restore damaged tissues
Artificial Intelligence Strengthens Cybersecurity as Threats Grow More Sophisticated
Artificial Intelligence Strengthens Cybersecurity as Threats Grow More Sophistic …
The global Artificial Intelligence in cybersecurity market size was USD 23.8 Billion in 2023 and is expected to reach a market valuation of USD 29.44 billion by the end of 2024 registering a CAGR of 23.7% during the forecast period. The adoption of Artificial Intelligence (AI) in cybersecurity is rapidly gaining traction as organizations worldwide face increasingly complex and frequent cyber threats. By combining advanced technologies such as Machine Learning
Global Regenerative Medicine Market to Reach USD 125.6 Billion by 2034, Growing at 13.9% CAGR
Global Regenerative Medicine Market to Reach USD 125.6 Billion by 2034, Growing …
The global regenerative medicine market, valued at USD 34.2 billion in 2024, is set to grow to USD 125.6 billion by 2034, expanding at a compound annual growth rate (CAGR) of 13.9%. Growth is being fueled by rising approvals of advanced therapies, strong demand for personalized treatments in cancer and orthopedics, and expanding cell and gene therapy manufacturing across major markets such as North America, Europe, and Asia. Once seen as

All 5 Releases


More Releases for Embolotherapy

Embolotherapy Market Size Expected to Hit $10.68 Billion by 2032
According to Value Market Research, the global Embolotherapy Market size is anticipated to experience significant growth, with expectations to reach nearly USD 10.68 billion by 2032, up from USD 4.87 billion in 2023. This growth corresponds to a robust compound annual growth rate (CAGR) of 9.12% during the forecast period from 2024 to 2032. The expansion of the market is attributed to advancements in embolotherapy technologies, increasing prevalence of chronic
Embolotherapy Market Future Prediction Report By 2031
Embolotherapy Market business research report assesses the current as well as upcoming performance of the market, also brand-new trends in the market. It provides product overview and highlights of product and application segments of the market including price, revenue, sales, sales growth rate, and market share by product. The market statistics within the report is displayed in a statistical format to offer a better understanding upon the market dynamics. Request Sample
Embolotherapy Market Revenue to Reach US$ 5,758.28 Million by 2028
The embolotherapy market is expected to grow from US$ 3,341.49 million in 2021 to US$ 5,758.28 million by 2028; it is estimated to grow at a CAGR of 8.1% from 2022 to 2028. According to our new research study on "Embolotherapy Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Product, Disease Indication, Procedure, and End User," the market is expected to grow from US$ 3,341.49 million in
Embolotherapy Market 2023 Size, Share, Growth Report 2030
Latest Updated Report 2023, The Global Embolotherapy Market to Growing A CAGR of % during forecast period of 2023-2030. The Market is segmented by Global Embolotherapy Market Breakdown by Application (Hospitals and Clinics, Ambulatory Surgical Centers, Other End Users) by Type (Embolic Agents, Microspheres, Embolic Coils, Liquid Embolic Agents, Embolic Plug Systems, Detachable Balloons, Support Devices, Microcatheters, Guidewires) and by Geography (North America, South America, Europe, Asia Pacific, MEA). The Embolotherapy
Embolotherapy Market Growth, Development and Demand Forecast Report, 2030
The National Cancer Institute, under the U.S. Department of Health and Human Services, states that 76,080 new cases of kidney and renal pelvic cancer were diagnosed in the U.S. in 2021. Further, the Brain Aneurysm Foundation estimates that over 30,000 people suffer a brain aneurysm rupture every year in the U.S. Likewise, Brain Foundation of Migraine and Headache Australia states that approximately more than 2% of adults suffer from aneurysms
Embolotherapy Market 2022 - 2028 Worldwide Major Industry Players' Review
The "Global Embolotherapy Market Analysis to 2028" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of Embolotherapy Market with detailed market segmentation by type, application, end user and geography. The global Embolotherapy Market is expected to witness high growth during the forecast period. The report provides key statistics on the